U.S., Aug. 28 -- An application to own the trademark for 'OXULUMIS' has been filed on Mar. 05, 2025.
Owner(s):
Regeneron Pharmaceuticals, Inc.; 777 Old Saw Mill River Road, , NEW YORK
Goods and/or Services:
For: Combination drug delivery devices sold full containing pharmaceutical preparations for the treatment of retinal diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Combination drug delivery devices sold empty for the treatment of retinal diseases
Class(es): 026, 039, 044
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-08-26&serialNumber=99068812
Disclaimer: Curated by HT Syndication....